SAH is the stroke subtype with the least beneficial outcome for patients: 40% of the patients die within a month after the bleeding1 and survivors rarely have a clinically favorable outcome.
The large majority of spontaneous SAHs (80%) are caused by rupture of intracranial aneurysms which are mostly located along the anterior and posterior communicating artery, the basilar artery, and middle cerebral artery (MCA)2.
Such aneurysms are difficult to model in animals and therefore animal models of SAH are either performed by injection of blood into the subarachnoid space/cerebral ventricles or by endovascular perforation of a subarachnoid vessel.
Autologous blood injection into the cisterna magna is easy to perform and reproducible as the blood volume can be directly controlled3. Unfortunately some aspects of the SAH pathophysiology, e.g. the vessel injury, cannot be modeled by this procedure. Another technical approach for induction of SAH is the opening of an intracisternal vein4.
However, the intraluminal CWp at the MCA branch appears to be the procedure that models the pathophysiology in humans most closely5. The method was developed and first described in rats by Bederson and colleagues and at the same time by Veelken and colleagues6,7. Later the intraluminal perforation model was adapted to mice8,9. A filament is inserted into the external carotid artery (ECA) and advanced to the skull base via the internal carotid artery (ICA). At the branching point of the MCA the filament perforates the vessel and induces a bleeding into the subarachnoid space at the skull base. The blood then distributes into the remaining subarachnoid space along fissures and blood vessels. Bleeding is stopped by clot formation at the site of perforation, but rebleedings, which are often detrimental in patients10, can occur. Accordingly, the endovascular filament model became a widely used SAH model during the past few years. The most frequently mentioned drawback of the filament perforation model is that bleeding volume cannot be directly controlled and may therefore be variable. This variability can significantly be reduced by tight control of animal physiology and post-hemorrhagic ICP.
Mice have the great advantage that a large number of genetically modified strains are available. However, due to their small size surgical procedures tend to be more complex than in larger species, e.g. rats or rabbits. Therefore the downscaling of techniques developed for rats to mice often does not lead to the desired results, e.g. as mice have a very limited body weight and blood volume noninvasive techniques for blood pressure and blood gas analysis as well as for hemoglobin saturation and heart rate monitoring have to be applied whenever possible. Accordingly, the aim of the current publication is to describe the filament perforation model for SAH in mice and to demonstrate how this model can be performed in a standardized and highly reproducible manner.